Recent work from Wang et al. showed that the melanoma-associated antigen D4B (MAGED4B) and four-jointed box kinase 1 (FJX1) antigens in a DNA vaccine against head and neck squamous cell carcinoma (HNSCC) caused a powerful antitumor response in murine models. Here, FJX1 is linked to head and neck squamous cell carcinoma.